Cytokinetics Inc. buy Needham & Company LLC
Start price
01.03.23
/
50%
€40.60
Target price
01.03.24
€54.33
Performance (%)
63.79%
End price
02.03.24
€66.50
Summary
This prediction ended on 02.03.24 with a price of €66.50. The BUY prediction by Needham___Company_LL for Cytokinetics Inc. saw massive gains of 63.79%. Needham___Company_LL has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cytokinetics Inc. | 0.450% | 0.450% | 25.989% |
iShares Core DAX® | -1.042% | 2.220% | 14.279% |
iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% |
iShares Nikkei 225® | -0.044% | -1.680% | 5.941% |
iShares S&P 500 | -0.480% | 2.165% | 23.067% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $58.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten